Dr. Hyunwoo Paco Kang, MD

Dr. Kang practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Kang's NPI, 1861855157, was assigned on April 4, 2016. Dr. Kang graduated from Vagelos College of Physicians and Surgeons in 2015. Dr. Kang holds California license A150380.

Dr. Kang's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Kang's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Kang is also affiliated with Los Angeles General Medical Center. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Kang to 1 more hospital, 4 medical groups, 3 group practices and clinics, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 8 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dmand AI has Dr. Kang's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists arthritis, hip replacement, muscle pain, fibromyalgia, and limb pain, pelvic and hip fracture and removal of damaged skin or skin graft among the conditions Dr. Kang treats.

CMS data shows 313 Medicare services from Dr. Kang across 5 procedure codes in 2024, for 154 Medicare patients. Medicare paid $18,567 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 154 Medicare patients who saw Dr. Kang in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 47% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 44, with 50% women.

In 2024, Dr. Kang wrote 27 Medicare Part D claims for 13 patients. 100% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $141 in total drug cost.

Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Knee replacement: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Kang, published from 2017 to 2021. 2020 was the busiest year, with 4. Dr. Kang's most frequent co-authors are Nathanael David Heckmann, MD, Cory Kishi Hiro Mayfield, MD and Andrew Homere.

CMS Open Payments shows 36 general payments to Dr. Kang from 12 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 44% of the total. Stryker Corporation paid the most, $1,421.

Dr. Kang graduated from Vagelos College of Physicians and Surgeons in 2015.

Dr. Kang is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.